Xenon Pharmaceuticals (XENE) Q3 2024 Earnings

8AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.77
-0.72
-0.67
-0.62

Details

Expected EPS
-0.700152
Actual EPS
-0.75
Surprise EPS
-0.05
Surprise Percent
+7.12%

Description

Xenon Pharmaceuticals (XENE) has reported earnings of -0.75 per share for Q3 2024.

0 Comments

Share your thoughts